Carlsmed, Inc.
CARL
$9.83
$0.171.76%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.44M | 50.51M | 44.75M | 38.27M | 32.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.44M | 50.51M | 44.75M | 38.27M | 32.27M |
| Cost of Revenue | 13.61M | 12.47M | 11.30M | 9.94M | 8.25M |
| Gross Profit | 42.83M | 38.04M | 33.46M | 28.33M | 24.02M |
| SG&A Expenses | 57.91M | 51.60M | 44.64M | 38.66M | 34.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.57M | 81.09M | 70.71M | 62.97M | 56.78M |
| Operating Income | -34.13M | -30.57M | -25.95M | -24.70M | -24.51M |
| Income Before Tax | -32.60M | -29.63M | -25.74M | -25.03M | -24.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.60 | -29.63 | -25.74 | -25.03 | -24.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.60M | -29.63M | -25.74M | -25.03M | -24.54M |
| EBIT | -34.13M | -30.57M | -25.95M | -24.70M | -24.51M |
| EBITDA | -33.79M | -30.29M | -25.73M | -24.52M | -24.37M |
| EPS Basic | -2.53 | -3.67 | -4.49 | -6.14 | -6.22 |
| Normalized Basic EPS | -1.58 | -2.21 | -2.72 | -3.66 | -3.71 |
| EPS Diluted | -2.53 | -3.67 | -4.49 | -6.14 | -6.22 |
| Normalized Diluted EPS | -1.58 | -2.21 | -2.72 | -3.66 | -3.71 |
| Average Basic Shares Outstanding | 79.10M | 56.57M | 34.10M | 17.10M | 16.57M |
| Average Diluted Shares Outstanding | 79.10M | 56.57M | 34.10M | 17.10M | 16.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |